Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Fig. 1

Time-point comparison of changes in HRQOL domain scores in the 12 months prior to death. 12 months before, 12 months before death (n = 8); 9 months before, 9 months before death (n = 4); 6 months before, 6 months before death (n = 22); 3 months before, 3 months before death (n = 31); imminent death, less than 3 months before death (n = 40). * All values shown are median scores. ** Upper lines show statistically significant differences using Mann-Whitney U test (P < 0.05). HRQOL, health-related quality of life

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us